Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor Academic Article uri icon

Overview

MeSH Major

  • Gastrointestinal Stromal Tumors
  • Protein Kinase Inhibitors

abstract

  • Selected patients with metastatic GIST who have responsive disease or focal resistance to tyrosine kinase inhibitor therapy may benefit from elective surgical resection. Surgery for patients with metastatic GIST who have multifocal resistance is generally not indicated, and these patients should be considered for clinical trials of new systemic agents.

publication date

  • March 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1877004

Digital Object Identifier (DOI)

  • 10.1097/01.sla.0000236630.93587.59

PubMed ID

  • 17435539

Additional Document Info

start page

  • 347

end page

  • 52

volume

  • 245

number

  • 3